Molecular determinants essential for skeletal-type excitation-contraction (EC) coupling have been described in the cytosolic loops of the dihydropyridine receptor (DHPR) a1S pore subunit and in the carboxyl terminus of the skeletal-specific DHPR b1a-subunit. It is unknown whether EC coupling domains present in the b-subunit influence those present in the pore subunit or if they act independent of each other. To address this question, we investigated the EC coupling signal that is generated when the endogenous DHPR pore subunit a1S is paired with the heterologous heart/brain DHPR b2a-subunit. Studies were conducted in primary cultured myotubes from b1 knockout (KO), ryanodine receptor type 1 (RyR1) KO, ryanodine receptor type 3 (RyR3) KO, and double RyR1/RyR3 KO mice under voltage clamp with simultaneous monitoring of confocal fluo-4 fluorescence. The b2a-mediated Ca 21 current recovered in b1 KO myotubes lacking the endogenous DHPR b1a-subunit verified formation of the a1S/b1a pair. In myotube genotypes which express no or low-density L-type Ca 21 currents, namely b1 KO and RyR1 KO, b2a overexpression recovered a wild-type density of nifedipine-sensitive Ca 21 currents with a slow activation kinetics typical of skeletal myotubes. Concurrent with Ca 21 current recovery, there was a drastic reduction of voltagedependent, skeletal-type EC coupling and emergence of Ca 21 transients triggered by the Ca 21 current. A comparison of b2a overexpression in RyR3 KO, RyR1 KO, and double RyR1/RyR3 KO myotubes concluded that both RyR1 and RyR3 isoforms participated in Ca 21 -dependent Ca 21 release triggered by the b2a-subunit. In b1 KO and RyR1 KO myotubes, the Ca 21dependent EC coupling promoted by b2a overexpression had the following characteristics: 1), L-type Ca 21 currents had a wildtype density; 2), Ca 21 transients activated much slower than controls overexpressing b1a, and the rate of fluorescence increase was consistent with the activation kinetics of the Ca 21 current; 3), the voltage dependence of the Ca 21 transient was bellshaped and the maximum was centered at ;130 mV, consistent with the voltage dependence of the Ca 21 current; and 4), Ca 21 currents and Ca 21 transients were fully blocked by nifedipine. The loss in voltage-dependent EC coupling promoted by b2a was inferred by the drastic reduction in maximal Ca 21 fluorescence at large positive potentials (DF/F max ) in double dysgenic/b1 KO myotubes overexpressing the pore mutant a1S (E1014K) and b2a. The data indicate that b2a, upon interaction with the skeletal pore subunit a1S, overrides critical EC coupling determinants present in a1S. We propose that the a1S/b pair, and not the a1S-subunit alone, controls the EC coupling signal in skeletal muscle.
INTRODUCTION
Excitation-contraction (EC) coupling in striated muscle is a fast process in which a brief depolarization causes an immediate elevation of the cytosolic Ca 21 (Kim and Vergara, 1998) . This process is brought about by a close interaction between the dihydropyridine receptor (DHPR) Ltype Ca 21 channel and the ryanodine receptor type 1 (RyR1) in skeletal muscle or type 2 (RyR2) in cardiac muscle. Close proximity between the DHPR and RyR complexes occurs at specialized junctions established between the transverse tubular and sarcoplasmic reticulum (SR) membranes . At these junctions, voltage-dependent movements of electrical charges in the skeletal DHPR are coupled to the opening of the RyR1 channel. However, the molecular mechanism that opens the RyR1 channel, including which DHPR subunits directly contribute to this process, is, for the most part, unknown. In contrast, activation of RyR2 channels in cardiac muscle is a Ca 21 -dependent process and is strictly proportional to the magnitude of the L-type Ca 21 current (Beuckelmann and Wier, 1988; Bers, 2002) . This fundamental difference in EC coupling trigger mechanism leads to significant differences in the voltage-dependence of Ca 21 transients. In skeletal muscle, the Ca 21 transient amplitude versus voltage relationship is sigmoidal whereas in cardiac muscle, it is bellshaped such that the Ca 21 transient is always proportional to the Ca 21 current. The biophysical and molecular details of SR Ca 21 release mediated by skeletal and cardiac RyR isoforms have been reviewed extensively (McPherson and Campbell, 1993; Coronado et al., 1994; Meissner, 1994; Sutko and Airey, 1996; Fill and Copello, 2002) .
In molecular terms, the skeletal DHPR is an ;430-kDa heteropentamer composed of a1S, b1a, a2-d1, and g1 subunits. The DHPR a1-subunit belongs to the superfamily of voltage-gated channel proteins with four internal repeats. Electrical charges in the S4 segments in each repeat move outward in response to membrane depolarization. This movement is coupled to the opening of the channel (Bezanilla, 2000) . b-subunits are ;65-kDa proteins that bind strongly to the cytosolic loop between repeats I and II of a1 via a conserved ;30-residue b interaction domain or BID De Waard et al., 1994) . b-subunits modulate the kinetics of activation and inactivation of the Ca 21 current Wei et al., 2000; Berrou et al., 2001) and strengthen the coupling between S4 charge movements and pore opening (Neely et al., 1993; Olcese et al., 1996; Kamp et al., 1996) . The molecular structure and function of the a2-d1 and g1 subunits of the skeletal DHPR are far less defined (Gurnett et al., 1996; Ahern et al., 2001c; Arikkath et al., 2003) .
Molecular studies of the EC coupling mechanism have relied on myotube models lacking specific DHPR subunits and RyR isoforms. Tanabe et al. (1988) utilized the a1S-null dysgenic myotube to show that the a1S pore subunit was essential for EC coupling signaling. In the dysgenic myotube, a base deletion leads to truncation and degradation of a1S and loss of voltage-activated Ca 21 transients. Transfection of cultured dysgenic myotubes with a1S cDNA leads to de novo synthesis of a1S-subunits (Ahern et al., 2001a,d) , concentration of the expressed DHPR in EC coupling junctions , and recovery of skeletal type EC coupling (Garcia et al., 1994 ). This expression system permitted studies in which the missing a1S Ca 21 pore isoform was replaced by a1C, the cardiac/ brain pore variant (Tanabe et al., 1990) . The Ca 21 fluorescence versus voltage curve expressed by a1C in dysgenic myotubes had a maximum at ;130 mV followed by a continuous decrease at more positive potentials. The biphasic nature of this relationship, along with a dependence of Ca 21 transients on external Ca 21 , showed that Ca 21dependent EC coupling could be implemented in skeletal myotubes by a hybrid DHPR composed of a cardiac pore subunit and the nonpore subunits expressed endogenously in the dysgenic myotube. The expression of chimeras of a1S and a1C were later used to demonstrate that a domain within the cytosolic loop linking repeats II and III of a1S (a1S L720-Q765) harbored a unique signal essential for skeletal type EC coupling (Nakai et al., 1998a) . The studies in dysgenic myotubes have led to the view that the a1S-subunit is the major contributor to the signal transduction and that the a1S II-III loop may be directly responsible for opening RyR1. However, in a strict sense, the observations in dysgenic myotubes cannot exclude the participation of other DHPR subunits in the EC coupling signal since these subunits (a2-d1, b, g1) are constitutively expressed in the dysgenic myotube (Arikkath et al., 2003) . Hence, if EC coupling domains were to be present in other subunits of the skeletal DHPR, they would have escaped detection in the dysgenic myotube by virtue of being constitutively present. In support of this premise, deletion analysis of the critical a1S L720-Q765 domain suggests that regions other than a1S II-III loop participate in skeletal-type EC coupling (Ahern et al., 2001b) .
Gene targeting techniques have substantially increased the number of myotube models that can be used as expression platforms for EC coupling studies. Gregg et al. (1996) described a knockout (KO) of the mouse b1 gene, encoding DHPR b isoforms expressed in skeletal muscle (b1a) and brain (b1b, b1c) (Powers et al., 1992) . The b1 KO mutation, like the dysgenic mutation, is perinatally lethal due to the absence of EC coupling in the skeletal musculature. The b1 KO myotubes fail to contract in response to electrical stimulation despite the presence of normal action potentials, Ca 21 storage capacity, and caffeine-sensitive Ca 21 release. However, b1 KO cells lack L-type Ca 21 current, and depolarization does not produce Ca 21 transients (Gregg et al., 1996; Strube et al., 1996) . Expression of the skeletal muscle b1a isoform in cultured b1 KO myotubes resulted in the recovery of the wild-type (WT) L-type Ca 21 current density, the intramembrane charge movement density, and the amplitude and voltage dependence of Ca 21 transients (Beurg et al., 1997) . In contrast, expression of the cardiac/brain b2a variant recovered L-type Ca 21 currents, but the amplitude of depolarization-activated Ca 21 transients was drastically depressed. Because the interaction between the DHPR a1and b-subunits is essential for cell surface expression (Chien et al., 1995; Bichet et al., 2000) , the loss of EC coupling in the b1 KO myotube could be exclusively due to the loss of DHPR voltage sensors from the cell surface. Alternatively, domains of the DHPR b1a-subunit, similar to elements present in the a1S-subunit, might be directly involved in activation of RyR1 channels. To examine the role of DHPR b1a in skeletal-type EC coupling, we chimerized b1a and the cardiac/brain b2a variant and mapped the domain(s) required for functional recovery of skeletal-type EC coupling in cultured b1 KO myotubes (Beurg et al., 1999a,b; Sheridan et al., 2003a) . DHPR b-subunits share two conserved central regions amounting to more than half of the total peptide sequence (domains D2 and D4), a nonconserved linker between the two conserved domains (D3), a nonconserved amino terminus (D1), and a nonconserved carboxyl terminus (D5) (Perez-Reyez and Schneider, 1994) . We tested the participation of D1, D3, and D5 of b1a in the recovery of Ca 21 conductance, charge movements, and EC coupling in b1 KO skeletal myotubes (Beurg et al., 1999a; Sheridan et al., 2003a) . Deletion of the D5 region of b1a (b1a residues 470-524) drastically reduced the amplitude of voltageevoked Ca 21 transients without affecting the density of DHPR charge movements. Thus, the membrane density of DHPR voltage sensors, critical for voltage-dependent EC coupling, was not compromised by the carboxyl terminal deletion. On the basis of this result, we have implicated the D5 region of b1a specifically in skeletal-type EC coupling (Sheridan et al., 2003a) . Recent recombinant protein binding studies indicate that the D5 domain is essential for strong interaction between DHPR b1a and a specific cytoplasmic region of RyR1 .
Targeted disruption of the three mammalian RyR genes has been described (Takeshima et al., 1994 Nakai et al., 1996; Bertocchini et al., 1997) . Two of these variants, namely RyR1 and RyR3, contribute to EC coupling in skeletal muscle. Absence of RyR1 leads to a full loss of skeletal-type EC coupling. Therefore, the RyR1 KO mutation is also perinatally lethal. Moreover, transient expression of RyR2 or RyR3 in the RyR1-deficient myotube does not lead to a recovery of skeletal EC coupling function (Yamazawa et al., 1996; Nakai et al., 1997; Fessenden et al., 2000) . In contrast to RyR1-deficiency, RyR3-deficiency affects dynamic aspects of muscle tension during the embryonic stage and slows Ca 21 transient propagation (Bertocchini et al., 1997; Yang et al., 2001) . However, RyR3 is not essential for mouse survival. Such a nonequivalent behavior of RyR1 and RyR3 variants suggests that highly specific interactions between RyR1 and the skeletal DHPR are essential for Ca 21 signaling in skeletal myotubes. This notion has been corroborated by the identification of RyR1 domains involved in skeletal-type EC coupling using chimeras of RyR1 and RyR2 or RyR1 and RyR3 (Yamazawa et al., 1997; Nakai et al., 1998b; Perez et al., 2003) .
In this study, we used KO myotubes lacking DHPR b1, RyR1, and RyR3 to examine the characteristics of the EC coupling induced by the heterologous cardiac/brain b2a variant in the context of myotubes expressing a WT a1Ssubunit. This interest was prompted by the observation that many of the carboxyl terminal deletion mutants of the D5 region of b1a, when expressed in b1 KO myotubes, induced Ca 21 transients triggered by the Ca 21 current (Sheridan et al., 2003a) . Hence, the EC coupling mechanism induced by the modified skeletal b1a variants shared many characteristics with the EC coupling process described in the heart. This result begs the question of whether a heterologous DHPR b variant from a gene predominantly expressed in cardiac tissues might be able to transform the skeletal EC coupling process to one more closely resembling cardiac EC coupling. We show that overexpression of the WT cardiac/brain b2a variant (Perez-Reyez and Schneider, 1994) produces drastic changes in EC coupling characteristics of cultured skeletal myotubes, altering it from a purely voltage-dependent process to one controlled mostly by the Ca 21 current. The changes are functionally equivalent to those observed in dysgenic myotubes expressing the cardiac/brain a1C variant in the context of the WT DHPR b1a-subunit. The results are consistent with the view that the DHPR b-subunit, like a1, is a key structural determinant of EC coupling in muscle cells. Part of this work has been previously published in abstract form (Sheridan et al., 2002 (Sheridan et al., , 2003b .
MATERIALS AND METHODS

Identification of genotypes
We used polymerase chain reaction (PCR) assays to screen for the WT and mutant alleles of the DHPR a1S, b1, RyR1, and RyR3 genes in mice with targeted disruptions of these genes (Gregg et al., 1996; Nakai et al., 1996; Bertocchini et al., 1997) or, in the case of muscular dysgenesis mice (mdg), carrying a frame-shifted a1S-null gene (Chaudhari, 1992) . Tail samples were digested with proteinase K (Sigma, St. Louis, MO), and the DNA was then isolated following the Puregene animal tissue protocol (Gentra Systems, Minneapolis, MN). The PCR reactions for each sample were composed of 11.7 mL distilled water, 1 mL of each 20 mM primer, 3.2 mL of 1.25 mM dNTPs (Stratagene, Cedar Creek, TX), 2 mL 103 PCR buffer (Qiagen, Valencia, CA), 1.2 mL Taq polymerase (Qiagen), and 1 mL of the DNA sample (;100 mg/mL).
DHPR a1S alleles
PCR primers 59 ttt ccc aca ggc cgt gct gct gct ctt ca 39 and 59 gca gct ttc cac tca gga ggg atc cag tgt 39 were used to amplify a 202-bp fragment of the WT a1S allele. PCR primers 59 gca gct ttc cac tca gga ggg atc cag tgt 39 and 59 ttt ccc aca ggc cgt gct gct gct ctt aga 39 were used to amplify a 203-bp fragment of the mdg allele (a1S-null). The following conditions apply for the PCR of both DHPR a1S alleles: 1), 2 min at 948C; 2), 45 s at 948C; 3), 45 s at 608C; 4), 1 min at 728C; 5), cycle through steps 2-4 for 30 times; and 6), 10 min at 728C.
DHPR b1 alleles
PCR primers 59 gag aga cat gac aga ctc agc tcg gag a 39 and 59 aca ccc cct gcc agt ggt aag agc 39 were used to amplify a 250-bp fragment of the WT b1 allele. PCR primers 59 aca ccc cct gcc agt ggt aag agc 39 and 59 aca ata gca ggc atg ctg ggg atg 39 were used to amplify a 197-bp fragment of the KO b1 allele. The following conditions apply for the PCR of both DHPR b1 alleles: 1), 2 min at 948C; 2), 30 s at 948C; 3), 45 s at 608C; 4), 1 min at 728C; 5), cycle through steps 2-4 for 30 times; and 6), 10 min at 728C.
RyR1 alleles
PCR primers 59 gga ctg gca aga gga ccg gag 39 and 59 gga agc cag ggc tgc agg tga gc 39 were used to amplify a 400-bp fragment of the WT RyR1 allele. PCR primers 59 gga ctg gca aga gga ccg gag 39 and 59 cct gaa gaa cga gat cag cag cct ctg ttc c 39 were used to amplify a 300-bp fragment of the KO RyR1 allele. The following conditions applied for the PCR of both RyR1 alleles: 1), 5 min 30 s at 948C; 2), 1 min at 948C; 3), 1 min at 578C; 4), 1 min at 728C; 5), cycle through steps 2-4 for 35 times; and 6), 10 min at 728C.
RyR3 alleles
PCR primers 59 cac atc cca atc tcc ttt act cc 39 and 59 gct tat tct gcc cta atg cca c 39 were used to amplify a 316-bp fragment of the WT RyR3 allele. PCR primers 59 ggt cat cct cac ttc gcc tat gtt c 39 and 59 cgt gct act tcc att tgt cac gtc 39 were used to amplify a 920-bp fragment of the KO RyR3 allele. The following conditions apply for the PCR of both RyR3 alleles: 1), 2 min at 948C (hot start followed by addition of Taq polymerase (Qiagen); 2), 3 min at 948C; 3), 1 min at 588C; 4), 2 min at 728C; 5), cycle through steps 2-4 for 35 times; and 6), 10 min at 728C.
Primary cultures
Cultures of myotubes were prepared from hind limbs of E18 fetuses, as described previously (Beurg et al., 1997) . Muscles dissected from the fetuses were treated with 0.125% (w/v) trypsin and 0.05% (w/v) pancreatin. After centrifugation, mononucleated cells were resuspended in plating medium containing 78% Dulbeccos's modified Eagle's medium with low glucose (DMEM), 10% horse serum, 10% fetal bovine serum (FBS), and 2% chicken serum extract. Cells were plated on plastic culture dishes coated with gelatin at a density of ;1 3 10 4 cells per dish. Cultures were grown at 378C in 8% CO 2 gas. After myoblast fusion (;6 days), the medium was replaced with FBS free medium, and CO 2 was decreased to 5%.
Double a1S/b1-null myotubes E18 fetuses lacking a1S and b1a were obtained by screening litters of fetuses from crosses of double heterozygous dysgenic and b1 KO mice (a1S 1/mdg , b1 1/ÿ 3 a1S 1/mdg , b1 1/ÿ ) as described (Ahern et al., 1999; . Mutant fetuses were visually recognized by the absence of muscle movements and were separately processed for myotube cell culture while a PCR screen was conducted in parallel. Limb myotube cultures from double null E18 fetuses with the genotype a1S mdg/mdg , b1 ÿ/ÿ were utilized in cDNA transfection protocols and are identified in the text as double dysgenic/b1 KO myotubes. cDNA transfection cDNA transfection was performed during the myoblast fusion stage with the polyamine LT1 (Panvera, Madison, WI). Cells were exposed for 2-3 h to a transfection solution containing LT1 and cDNA at a 5:1 mg ratio. In addition to the cDNA of interest, cells were cotransfected with a plasmid encoding the T-cell protein CD8, which is used as a transfection marker. Transfected myotubes expressing CD8 were recognized by surface binding of polystyrene beads coated with a monoclonal antibody specific for an external CD8 epitope (Dynal ASA, Oslo, Norway). The efficiency of cotransfection of the marker and the cDNA of interest was ;90%. Wholecell analysis of Ca 21 currents and Ca 21 transients was performed 3-5 days after transfection.
cDNA constructs cDNAs for mouse b1a (residues 1-524; GenBank accession no. NM_031173) and rat b2a (residues 1-604; GenBank accession no. M80545) were subcloned into the pCR-Blunt vector (Invitrogen, Carlsbad, CA), excised by digestion with AgeI and NotI, and cloned into the pSG5 vector in frame with the first 11 residues of the phage T7 gene 10 protein for antibody tagging. The a1S (E1014K) substitution was introduced in a rabbit a1S template (GenBank accession no. M23919) and was described previously (Ahern et al., 2001b) . WT a1S and a1S (E1014K) were fused in-frame to the first 11 amino acids of the phage T7 gene 10 protein in the pSG5 vector.
Whole-cell voltage clamp
Whole-cell recordings were performed as described previously (Strube et al., 1996) with an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). Effective series resistance was compensated up to the point of amplifier oscillation with the Axopatch circuit. All experiments were performed at room temperature. The external solution was (in mM) 130 TEA methanesulfonate, 10 CaCl 2 , 1 MgCl 2 , 10 ÿ3 TTX, 10 HEPES titrated with TEA(OH) to pH 7.4. The pipette solution consisted of (in mM) 140 Cs aspartate, 5 MgCl 2 , 0.1 EGTA (when Ca 21 transients were recorded) or 5 EGTA (when only Ca 21 currents were recorded), and 10 MOPS titrated with CsOH to pH 7.2. Patch pipettes had a resistance of 1-1.5 MV when filled with the pipette solution. The limit of Ca 21 current detection was ;20 pA/cell or ;0.05 pA/pF for the smallest cells having the lowest capacitative noise.
Confocal fluorescence microscopy
Confocal line scan measurements were performed as described previously (Conklin et al., 1999) . All experiments were performed at room temperature. Cells were loaded with 5 mM fluo-4 acetoxymethyl (AM) ester (Molecular Probes, Eugene, OR) for 60 min at room temperature. Cells were viewed with an inverted Olympus microscope with a 203 objective (N.A. ¼ 0.4) and a Fluoview confocal attachment (Olympus, Melville, NY). A 488-nm spectrum line for fluo-4 excitation was provided by a 5-mW Argon laser attenuated to 6% with neutral density filters. For voltage-activated Ca 21 transients, line scans consisted of 1000 lines, each of 512 pixels, acquired at a rate of 2.05 milliseconds per line. Line scans were synchronized to start 100 ms before the onset of the depolarization. For Ca 21 transients activated by caffeine or CMC (4-chloro-m-cresol, Sigma, St. Louis, MO), line scans consisted of 1000 lines, each of 512 pixels, acquired at a rate of 30.8 milliseconds per line. Line scans were synchronized to start 800 ms before the onset of the external solution change. The time course of the spaceaveraged fluorescence intensity change and DF/F units were estimated as follows: 1), The pixel intensity in a line scan was transformed into arbitrary units, and the mean intensity of each line was obtained by averaging pixels covering the cell exclusively; 2), The mean resting fluorescence intensity (F) corresponds to the mean intensity of each line averaged before stimulation and was used as a baseline; 3), The change in mean line intensity above baseline (DF) was obtained by subtraction of F (baseline) from the mean line intensity; 4), DF was divided by the baseline F for each line in a line scan and was plotted as a function of time. The peak-to-peak noise in the baseline fluorescence averaged ;0.1 DF/F units which was previously estimated to correspond approximately to a 200-nM change in free Ca 21 (Conklin et al., 1999) . Since DF/F was spatially averaged, noise varied with spatial inhomogeneities in fluo-4 fluorescence and cell size. The smallest fluorescence signals reported in this study were ;0.2 DF/F in b2aoverexpressing RyR1/RyR3 KO myotubes and ;0.4 DF/F in b2aoverexpressing RyR1 KO myotubes (Table 2). To construct peak Ca 21 fluorescence versus voltage curves, we used the highest DF/F line value after the onset of the pulse and up to the termination of the pulse. Image analyses were performed with NIH Image software (National Institutes of Health, Bethesda, MD). To obtain reliable Ca 21 transient versus voltage curves, seven-step depolarizations of 50 ms or 200 ms were applied in descending order (from 190 mV to ÿ30 mV) from a holding potential of ÿ40 mV. Between each depolarization, the cell was maintained at the resting potential for 30 s to permit recovery of the resting fluorescence.
Immunostaining
Four to five days after transfection, cells were fixed in 100% methanol and processed for immunostaining as described previously (Gregg et al., 1996) . The primary antibody was a mouse monoclonal against the T7 epitope (Novagen, Madison, WI) present in b1a and b2a and was used at a dilution of 1:1000. The secondary antibody was a fluorescein conjugated polyclonal goat anti-mouse IgG (Boehringer Mannheim, Indianapolis, IN) and was used at a dilution of 1:1000. Confocal images of 0.3 to 0.4 microns per pixel were obtained in the Olympus Fluoview using a 403 oil-immersion objective (N.A. ¼ 1.3). Images were Kalman-averaged 3 times, and the pixel intensity was displayed as 16 levels of gray in reverse. All images were acquired with minimal laser power (6% of maximum 5 mW) and predetermined PMT settings to avoid pixel saturation and for accuracy in the comparison of images.
Curvefitting
The voltage dependence of the Ca 21 conductance and peak fluorescence, assayed with the 50-ms depolarization, was fitted in all cases according to a Boltzmann distribution (Eq. 1)
where A max is G max or DF/F max , V1/2 is the potential at which A ¼ A max /2, and k is the slope factor. For myotubes overexpressing b1a, the voltage dependence of peak fluorescence assayed with a 200-ms depolarization was fit with Eq. 1. The b2a variant produced biphasic bell-shaped fluorescence versus voltage curves with varying degrees of curvature. For myotubes overexpressing b2a, the voltage dependence of peak intracellular Ca 21 assayed with a 200-ms depolarization was fit with the modified Boltzmann distribution (Eq. 2)
where (VÿVr) is a factor that accounts for the decrease in Ca 21 current trigger at positive potentials and k9 is a scaling factor that varies with the magnitude of DF/F max . Other parameters are the same as in Eq. 1.
Parameters of a fit of averages of many cells (population average) are shown in figures. The statistics of parameters of the fit of individual cells are shown in Table 1 . Student's t-tests and analysis of variance (ANOVA) were performed with Analyze-it software (Analyze-it, Leeds, UK).
RESULTS
Previous studies showed that b1 KO myotubes expressing the heterologous DHPR b2a-subunit had weak Ca 21 transients compared to controls expressing the skeletal muscle-specific b1a-subunit (Beurg et al., 1999a,b; Sheridan et al., 2002 Sheridan et al., , 2003b . Here we demonstrate that b2a induces Ca 21 transients triggered by the Ca 21 current, and furthermore, both RyR isoforms described in primary skeletal myotubes are implicated in the functional changes. To separate the contributions of RyR1 and RyR3, we characterized functional expression of b2a in cultured primary myotubes from RyR1 KO, RyR3 KO, and double RyR1/ RyR3 KO mice. Interbreeding mice heterozygous of the RyR1 KO allele and homozygous for the RyR3 KO allele produced RyR1/RyR3 KO mice (Ikemoto et al., 1997; Barone et al., 1998; Conklin et al., 2000) . Genotypes were screened by PCR as described in Materials and Methods. Additional controls were performed in b1 KO myotubes lacking the endogenous b1a variant. The two DHPR b variants investigated, namely the heterologous rat b2a and the homologous mouse b1a used as a reference, carried a T7 epitope tag fused to the amino terminus for determining relative levels of protein expression in transfected cells. Fig.  1 shows confocal anti-T7 immunofluorescence in four myotube genotypes expressing the homologous and heterologous DHPR b variants. The cDNA of interest was cotransfected with the CD8 cDNA, which was used to identify viable transfected myotubes in voltage-clamp experiments. Dishes of transfected cells were incubated with anti-CD8 antibody beads, fixed, and processed for immu-nostaining with anti-T7 antibody. Protein expression was determined 4-5 days after transfection. Voltage-clamp experiments have determined that this transfection time is adequate for full functional recovery of EC coupling properties in b1 KO myotubes (Beurg et al., 1997) . At this stage of protein expression, we found abundant b-protein throughout the myotube with the exclusion of the cell nuclei. Based on fluorescence intensity, we estimated that all myotube genotypes overexpressed exogenous b2a and b1a proteins at comparable levels.
Transcripts for RyR3 have been detected in primary cell cultures of WT and RyR1 KO limb myotubes (Takeshima et al., 1995) . Furthermore, functional RyR3 channels account for caffeine-induced Ca 21 release and Ca 21 sparks detected in embryonic RyR1 KO myotubes (Takeshima et al., 1995; Conklin et al., 2000) . In contrast, RyR3 has been reported to be absent in a myogenic cell line derived from RyR1 KO embryonic limb myotubes (Fessenden et al., 2000) . To determine whether one or two RyR variants were present in our primary cell cultures, we conducted Ca 21 release studies using caffeine and the high-affinity RyR1 agonist CMC (Herrmann-Frank et al., 1996) . In these experiments, cells were loaded with fluo-4 AM, and SR Ca 21 release was induced by fast perfusion of external solution supplemented with caffeine (10 mM) or CMC (0.5 mM). The perfusion solution was passed through a largebore pipette placed near the cell with the pipette connected to a pressurized manifold (ALA Scientific, Westbury, NY) and synchronized to confocal line scan image acquisition. Fig. 2 shows Ca 21 transients evoked by fast perfusion of caffeine or CMC in WT, RyR3 KO, RyR1 KO, and RyR1/RyR3 KO myotubes. As indicated by the line diagram above each trace of fluorescence, the external solution change lasted 4 s and was initiated 800 ms after the start of the line scan. After the pulse of agonist, line scan acquisition was continued for an additional 26 s. The time course of the space-averaged confocal fluorescence intensity was computed from the line scan image and is shown in DF/F units. A rapid increase in myotube fluorescence was observed in response to caffeine in WT and RyR3 KO myotubes. Comparatively weaker and slower responses to caffeine were present in ;60% of the tested RyR1 KO myotubes (26 of 41 cells) with the rest entirely unresponsive to caffeine. Caffeine had no effect in double RyR1/RyR3 KO myotubes (14 of 14 cells). The presence of caffeine-sensitive Ca 21 pools in RyR1 KO and RyR3 KO, but not in RyR1/RyR3 KO myotubes, confirmed the presence of these two RyR isoforms in our cell cultures and was consistent with previous studies (Takeshima et al., 1995; Conklin et al., 2000) . However, since the response to caffeine in RyR1 KO myotubes was heterogeneous, functional RyR3 channels may not be present in all RyR1deficient cells. Alternatively, RyR3 channels may not be responsive to caffeine in all cells for some unknown reason. Fig. 2 also shows that large and fast responses to CMC were observed in WT and RyR3 KO myotubes, and much weaker (Fessenden et al., 2000) , it is likely that the differential sensitivity to caffeine reflects differences in the functional density of RyRs with RyR1 present at a much higher density than RyR3, respectively, in RyR3 KO and RyR1 KO myotubes. It is also possible that RyR1 expression may be up-regulated in RyR3 KO myotubes relative to WT since CMC responses were significantly higher in the former than the latter. In summary, the Ca 21 release responses to caffeine and CMC show that functional RyR1 and RyR3 are present, respectively, in RyR3 KO and most RyR1 KO cultured myotubes. Fig. 3 shows Ca 21 conductance versus voltage relationships in myotubes transfected with each of the two DHPR b isoforms (b1a and b2a in top and bottom rows, respectively) in each of four genotypes (b1 KO, RyR3 KO, RyR1 KO, and RyR1/RyR3 KO in columns from left to right). b2a-transfected myotubes were compared to b1a-transfected myotubes even though both RyR KO genotypes are likely to express a native DHPR that includes b1a. We felt that in the case of the RyR KO genotypes, myotubes with exogenous b1a overexpression provided a better control than nontransfected myotubes since overexpression eliminated potential phenotypic changes introduced by an unknown up-or down-regulation of endogenous b1a. However, this concern was largely unfounded. The insets show whole-cell Ca 21 currents elicited by 500-ms depolarizations to ÿ10 and 130 mV from a holding potential of ÿ40 mV. The complete pulse protocol utilized for fitting conductance versus voltage curves consisted of 500-ms step depolarizations from ÿ35 mV to 160 mV every 5 mV. The gray lines in each plot indicate the mean conductance of nontransfected myotubes. We found that nontransfected b1 KO myotubes had marginally detectable Ca 21 currents in agreement with previous studies . In b1a-expressing b1 KO myotubes, we consistently detected a high-density Ca 21 current with a maximal conductance, G max , and other Boltzmann parameters, similar to those of WT myotubes (Table 1) . Thus, as shown previously (Beurg et al., 1997) , b1a overexpression in the b1 KO myotube recovered the normal Ca 21 current phenotype. Furthermore, the Ca 21 current density of WT myotubes was similar to that reported previously by others and us (Beurg et al., 1997; Strube et al., 1998; Avila and Dirksen, 2000) . Averages of Boltzmann parameters fitted to the conductance versus voltage curve of each cell and the statistical significance of the data are shown FIGURE 1 b-protein expression in b1 KO and RyR KO myotubes. Confocal immunofluorescence of myotubes expressing T7-tagged DHPR b1aor b2a-subunits. Cells with the indicated genotype were transfected with CD8 cDNA plus the b1a or b2a cDNA. b1a corresponds to the full-length mouse cDNA; b2a corresponds to the fulllength rat cDNA. Cells were incubated with CD8 antibody beads, fixed, and stained with anti-T7 primary/fluoresceinconjugated secondary antibodies. Pixel intensity was converted to a 16-level inverted gray scale with highintensity pixels in black color. Images are 84 3 56 microns and on-focus beads are 4.5 microns in diameter. The asterisk indicates a nontransfected myotube in the same focal plane as the transfected cell.
in Table 1 . Overexpression of b1a in the RyR3 KO myotube did not increase Ca 21 current density beyond that present in nontransfected RyR3 KO myotubes, which was entirely normal (G max ¼ 182 6 15 pS/pF, n ¼ 4 cells versus 162 6 15 pS/pF, n ¼ 9 cells for nontransfected and b1a-transfected, respectively). In RyR1 KO and RyR1/RyR3 KO myotubes, the endogenous Ca 21 current density was severely depressed, and b1a overexpression failed to increase it beyond levels present in nontransfected cells. The G max of nontransfected RyR1 KO and RyR1/RyR3 KO myotubes were 27 6 5 pS/pF (14 cells) and 24 6 10 pS/pF (4 cells), respectively. These values were statistically similar to the density of b1a-transfected RyR1 KO and RyR1 KO/RyR3 KO myotubes shown in Table 1 . The inability of exogenous b1a overexpression to increase the Ca 21 current density in RyR1-deficient myotubes was not surprising in light of the known fact that RyR1 is a strong enhancer of the native DHPR Ca 21 current (Nakai et al., 1996; Avila et al., 2001; Ahern et al., 2003) . Thus, absence of RyR1, and not the endogenous level of the DHPR b1a-subunit, may be the limiting factor for Ca 21 current expression in the RyR1deficient genotypes. In b1 KO myotubes, b2a expressed a high-density Ca 21 current with a G max similar to that recovered by b1a (Table 1) . Moreover, the half-activation potential and voltage dependence of the Ca 21 current expressed by the b1a and b2a were also similar. Also, previous studies had shown that Ca 21 currents recovered by b1a and b2a had similar mean-variance noise characteristics and activation kinetics (Beurg et al., 1999b) . Hence it is highly likely that b2a became integrated into a functional skeletal DHPR with the pore subunit a1S providing the pathway for the Ca 21 current. The fate of the two other subunits of the DHPR in this hybrid complex is not known. However, their presence in the complex is suggested by the complete normalcy of the Boltzmann parameters of the Ca 21 conductance recovered by b2a (Table 1) . b2a overexpression in RyR1 KO myotubes was recently shown to restore a slow Ca 21 current with an entirely WT density . The bottom row of Fig. 3 confirmed this observation and further showed that b2a recovered highdensity Ca 21 currents in all genotypes analyzed, including double RyR1/RyR3 KO myotubes. In the RyR1 KO and RyR1 KO/RyR3 KO myotubes, b2a recovered Ca 21 currents with a density ;5 fold larger than that present in nontransfected cells and similar to that of WT myotubes (Table 1) . Thus, in contrast to the behavior of b1a, Ca 21 currents recovered by b2a readily bypassed the inhibition imposed by the absence of RyR1. Furthermore, the results in double KO myotubes showed that neither RyR1 nor RyR3 were required for DHPR Ca 21 current expression when the heterologous b2a-subunit was present in the DHPR complex. Given this drastic change in Ca 21 current expression pattern, we further tested if b2a was capable of recruiting a pore subunit other than a1S which could potentially be present in the cultured myotube and that could account for the Ca 21 currents recovered by b2a. Controls indicated that neither b1a nor b2a recovered Ca 21 currents when overexpressed in a1S-null dysgenic myotubes in similar cell culture conditions (not shown). Thus, non-a1S pore subunits, if present in skeletal myotubes, may not be able to combine with b1a or b2a to generate functional Ca 21 channels. This result strongly suggested that Ca 21 currents recovered by b2a in RyR1 KO and RyR1/RyR3 KO myotubes originated from hybrid DHPR complexes that included a1S and the exogenous b2a-subunit. A mechanism explaining how Ca 21 currents recovered by b2a bypass the requirement for RyR1 has been proposed elsewhere .
In b1 KO myotubes overexpressing b1a, the Ca 21 current has no bearing on the magnitude of the Ca 21 transient (Beurg et al., 1997) . However, recent studies showed that long depolarizations significantly increased the total Ca 21 entering the cell, and that the excess of Ca 21 entry triggered SR Ca 21 release when b1 KO myotubes overexpressed truncated variants of b1a (Sheridan et al., 2003a) . For this reason, possible changes in EC coupling produced by b2a overexpression were tested by voltage steps with a duration of 50 ms and 200 ms in the range of ÿ30 mV to 190 mV, which covered both the inward and outward phases of the myotube Ca 21 current. Fig. 4 shows confocal Ca 21 transients in response to 200-ms depolarizations to 130 and 190 mV from a holding potential of ÿ40 mV in the same myotube. Ca 21 currents were acquired concurrently, and they were similar in density to those described in Fig. 3 . The entire pulse protocol consisted of 50-ms and 200-ms depolarizations, and a comparison of Ca 21 transients stimulated by the two protocols is described below. Because the Ca 21 current becomes progressively smaller at potentials [30 mV, as the imposed voltage approaches the Ca 21 current reversal potential and the Ca 21 equilibrium potential, a contribution of the Ca 21 current as trigger of the Ca 21 transient can be readily deduced by comparing Ca 21 transients at 130 mV and 190 mV. Fig. 4 shows that in b1 KO cells overexpressing b1a, Ca 21 transients had a nearly identical shape and magnitude at 130 and 190 mV. This result was consistent with the previous data (Beurg et al., 1999a,b; Sheridan et al., 2003a) and the well-known voltage dependence of skeletal-type EC coupling, which is unrelated to the fate of the Ca 21 current (Rios and Pizarro, 1991) . Similarly, Ca 21 transients in b1a-expressing RyR3 KO myotubes had the same maximal intensity at 130 and 190 mV, and this result agreed with previous determinations showing that RyR3 KO myotubes display skeletal-type EC coupling (Dietze et al., 1998) . In myotubes lacking RyR1 (RyR1 KO and RyR1/RyR3 KO), b1a overexpression failed to recover Ca 21 transients, which is not surprising since RyR3 is incapable of supporting skeletal-type EC coupling (Fessenden et al., 2000) . Additionally, the Ca 21 current density in the RyR1-deficient genotypes is noticeably small. Hence, Ca 21 -dependent Ca 21 release or a direct contribution of the Ca 21 current to the cell fluorescence would be difficult to detect in these cells. In contrast, Ca 21 transients of various magnitudes were detected in all myotube genotypes overexpressing b2a and were two-to fivefold smaller at 190 than at 130 mV (Fig. 4, bottom row) . Furthermore, in RyR1 KO and RyR1/RyR3 KO myotubes, b2a-mediated Ca 21 transients were seen at 130 but not at 190 mV, suggesting that a significant proportion of the fluorescence signal in these myotubes could arise from the Ca 21 current itself. b2amediated Ca 21 transients in b1 KO myotubes were smaller in magnitude than those in b1a-expressing b1 KO, in agreement with previous determinations (Beurg et al., 1999b) . In addition, the selected b2a-expressing RyR3 KO myotube shows Ca 21 transients larger than that of the b2aexpressing b1 KO myotube. However, on average, this difference was not significant ( Table 2 ). The results in b1 KO and RyR3 KO myotubes suggested that b2a expression changed the EC coupling signal from one that is controlled by voltage to one in which the Ca 21 current served as a trigger. We were especially surprised by the changes in the voltage dependence of Ca 21 transients in RyR3 KO myotubes since nontransfected RyR3 KO myotubes (Dietze et al., 1998) or b1a-overexpressing RyR3 KO myotubes (Fig. 4, top row) showed bona fide skeletal-type EC FIGURE 3 Ca 21 conductance expressed by the heterologous DHPR b2a-subunit in b1 KO and RyR KO myotubes. Myotubes with the indicated genotype (b1 KO, RyR3 KO, RyR1 KO, and double RyR1/RyR3 KO) were transfected with b1a (top row) or b2a (bottom row). Insets show representative Ca 21 currents at ÿ10 mV and 130 mV for a depolarization of 500 ms from a holding potential of ÿ40 mV. Lines correspond to a Boltzmann fit of the population mean Ca 21 conductance indicated in Table 1 . All conductance versus voltage curves were fit with Eq. 1. Parameters of the fitted lines, with G max in pS/pF, V1/2 in mV, and k in mV, were as follows: for b1 KO myotubes, were 194, 14.9, and 7 for b1a overexpression and 183, 11.6, and 5.2 for b2a overexpression; for RyR3 KO myotubes, were 162, 15.5, 6.1 for b1a and 156, 10.5, 5 for b2a; for RyR1 KO myotubes were 25, 17.9, 6.6 for b1a and 184, 13.2, 6.4 for b2a; for RyR1/RyR3 KO myotubes were 35, 25.8, 5.8 for b1a and 157, 14.6, 8 for b2a.
coupling. This result seemed to indicate that b2a behaved as a negative dominant subunit capable of disrupting normal DHPR function in the RyR3 KO myotube.
To determine how much of the fluorescence signal in b2aexpressing myotubes was due to the Ca 21 current and how much was due to SR Ca 21 release, we examined fluorescence versus voltage and Ca 21 current versus voltage relationships acquired concurrently. Fluorescence signals in RyR1/RyR3 KO myotubes should exclusively reflect the contribution of the Ca 21 current, whereas those in RyR1 KO should reflect the contribution of the Ca 21 current and Ca 21 entry dependent Ca 21 release mediated by RyR3. Consistent with this idea, Fig. 5 A shows that b2a-mediated Ca 21 transients in RyR1 KO (closed circles) and RyR1 KO/RyR3 KO (closed squares) myotubes had a bell-shaped dependence with a maximum at 130 mV, which coincided with the maximal Ca 21 current shown in Fig. 5 B. Additionally, the peak DF/F at 130 mV was larger in RyR1 KO than in RyR1 KO/RyR3 KO myotubes, whereas the Ca 21 current density was similar in both cases. The baseline for these curves was provided by the behavior of nontransfected RyR1 KO myotubes (open circles) and RyR1/RyR3 KO myotubes (open squares), which lacked Ca 21 transients entirely and expressed a minimal Ca 21 current. The peak DF/F of nontransfected myotubes was undistinguishable from the noise of the measurement, which was ;0.1 DF/F (see Materials and Methods). We surmise that the excess in cell fluorescence in b2a-expressing RyR1 KO myotubes, above that present in b2a-expressing RyR1 KO/RyR3 KO myotubes, should reflect SR Ca 21 release due to Ca 21dependent activation of RyR3. To confirm this idea, b2aexpressing RyR1 KO myotubes were treated with 5 mM ryanodine to block any RyR-dependent SR Ca 21 release. Fig. 5 C shows representative Ca 21 transients and Ca 21 currents at 130 mV in a b2a-expressing RyR1 KO myotube (black traces) and in a separate b2a-expressing RyR1 KO myotube treated with ryanodine (gray traces). To ensure a complete elimination of the fluorescence change due to EC coupling, myotubes were exposed to ryanodine for 30 min. For this reason, controls and ryanodine-treated cells were different. Myotubes were selected so that the Ca 21 current densities were approximately the same. Ryanodine treatment significantly reduced the fluorescence signal in b2a-expressing RyR1 KO myotubes and suggested that a significant 2.7 6 0.5 (10) ÿ3 6 2 7.7 6 0.5 1.0 6 0.1 3.4 6 0.6 (10) ÿ8 6 2 5.8 6 1.1 1.2 6 0.1 RyR3 KO 1 b1a 2.2 6 0.4 (10) ÿ6 6 2 8.6 6 1.1 1.2 6 0.1 3.3 6 0.6 (9) ÿ9 6 2 7.2 6 1.4 1.
0.9 6 0.2* (10) ÿ2 6 3 7.4 6 1.5 1.5 6 0. component of the fluorescence signal in b2a-expressing RyR1 KO myotubes was due to RyR-dependent SR Ca 21 release presumably mediated by RyR3. Since Ca 21 current densities in all b2a-expressing genotypes were roughly similar (Table 1) , we estimated the relative magnitude of the b2a-mediated Ca 21 release in all genotypes by normalizing the peak DF/F relative to the magnitude of the Ca 21 current at the same potential of 130 mV (Fig. 5 D) . The normalized signal in RyR1/RyR3 KO myotubes represents the direct contribution of the Ca 21 current to the cell fluorescence, and progressively larger signals due to SR Ca 21 release were present in RyR1 KO, RyR3 KO, and b1 KO myotubes. The largest Ca 21 release signals were observed in the RyR1expressing myotubes (b1 KO and RyR3 KO) consistent with the idea that RyR1 is expressed at a much higher density than RyR3 described above. Voltage-dependent components in b2a-transfected RyR3 KO and b1 KO myotubes also contributed to the fluorescence signal in these cells and are discussed separately (see Figs. 6 and 9 ). The cell fluorescence to Ca 21 current ratio at 130 mV was not statistically different for b2a-transfected RyR3 KO and b1 KO myotubes. However, this ratio was significantly smaller for b2a-transfected RyR1 KO and RyR1/RyR3 KO myotubes (t-test significance p \ 0.05) and is indicated by asterisks. The main conclusions from the comparison in Fig.  5 D are that the Ca 21 current has a modest impact on the measured myotube fluorescence and that both RyR isoforms (RyR1 and RyR3), when present, can be activated by the Ca 21 current recovered by b2a overexpression.
Ca 21 release triggered by the Ca 21 current follows the voltage dependence of the Ca 21 current. Hence, this EC coupling mechanism can be distinguished from purely voltage-dependent EC coupling by the shape of the Ca 21 fluorescence versus voltage relationship. Additionally, Ca 21 -dependent EC coupling should be a sensitive function of the duration of the depolarizing stimulus as longer depolarizations increase the amount of trigger Ca 21 entering the cell. Previous studies showed that depolarizations for 50 ms were adequate for activation of DHPR charge movements . However, activation of the Ca 21 current to near steady state required depolarizations of 200 ms (Sheridan et al., 2003a) . For these reasons, we investigated the shape of fluorescence versus voltage curves for depolarizations of 50 and 200 ms in the same cell. Fluorescence versus voltage relationships are shown in Fig. 6 for b1a and b2a overexpression in the four myotube genotypes under investigation. The DF/F value reached at the end of the depolarization was plotted as a function of voltage for depolarizations of 50 ms (closed symbols) and 200 ms (empty symbols). The gray traces indicate the mean fluorescence of nontransfected myotubes. The duration of the pulse did not affect the sigmoidal voltage dependence of Ca 21 transients expressed by b1a in b1 KO myotubes, which is in agreement with recent observation from our laboratory (Sheridan et al., 2003a) and studies in adult skeletal muscle (Melzer et al., 1986) . Interestingly, RyR3 KO myotubes overexpressing b1a had sigmoidal fluorescence versus voltage curves with a higher maximal fluorescence (DF/F max ) for the 200 ms than for the 50 ms stimulation. This difference was also observed in nontransfected myotubes (DF/F max ¼ 1.8 6 0.1 for 50 ms and 2.7 6 0.1 for 200 ms for four cells) and is shown by the two gray traces in the top and bottom graphs corresponding to RyR3 KO myotubes. However, the differences in DF/F max for 50-ms and 200-ms depolarizations were not significant either in b1a-transfected (see Table 2 ) or nontransfected RyR3 KO myotubes. A contribution of RyR3 to the overall rate of propagation of Ca 21 release has been previously reported in cultured RyR3 KO myotubes and could underlie the small difference in DF/F max observed here for the short and long depolarizations (Yang et al., 2001) . In RyR1 KO and RyR1/RyR3 KO myotubes, b1a overexpression failed to recover Ca 21 transients entirely, in agreement with the critical role of RyR1 in voltage-dependent coupling and the absence of b1a stimulated Ca 21 current expression in these genotypes. b2a overexpression changed the shape of the fluorescence versus voltage curve in the RyR1-expressing genotypes (b1 KO and RyR3 KO) and introduced Ca 21 transients in the RyR1-deficient genotypes (RyR1KO and RyR1/RyR3 KO) that were not present in nontransfected counterparts. In b1 KO and RyR3 KO myotubes, b2aoverexpression reduced the DF/F max produced by the 50-ms stimulation relative to that recovered by b1a, and furthermore, the fluorescence versus voltage curves generated with the 200-ms pulse were clearly bell-shaped. Bell-shaped curves were also observed for the 200-ms depolarization in RyR1 KO and RyR1/RyR3 KO myotubes but not for the 50ms depolarization. In all cases, the 200-ms depolarization produced an increase in fluorescence in the range of ÿ30 mV to 120 mV, a maximum at ;130 mV, and a decline in fluorescence in the range of 140 mV to 190 mV. To quantify these observations, we fitted the curves obtained with the 200-ms depolarization for b2a-expressing myotubes with a modified Boltzmann equation that takes into account the reversal potential of the Ca 21 current (Eq. 2), whereas the rest of the curves in Fig. 6 were fit with a conventional Boltzmann equation (Eq. 1). The degree of curvature of the fluorescence versus voltage plots at positive potentials was estimated by computing the ratio of fluorescence at the experimental maximum (exp max) for a given fluorescence versus voltage curve (typically 130mV) and the fluorescence at 190 mV ð½DF=F exp max=½DF=F190 mVÞ. The Boltzmann parameters of the fit of each cell and the fluorescence ratios at 50 ms and 200 ms are shown in Table  2 along with the statistical significance and the number of cells. In summary, a dependence of the Ca 21 transient amplitude on pulse duration was observed for b2a-overexpressing myotubes. This was reflected in the bell-shaped fluorescence versus voltage relationships, consistent with the presence of an EC coupling component triggered by the Ca 21 current in all myotube genotypes overexpressing b2a. Ca 21 transients were the smallest in RyR1/RyR3 KO myotubes, and, as mentioned previously, they reflected the fluorescence contributed by the Ca 21 current itself.
If the Ca 21 current triggered SR Ca 21 release in myotubes expressing b2a, the rate of rise of the fluorescence signal and the rate of Ca 21 entering the cell should have a similar time course. Fig. 7 shows Ca 21 transients and Ca 21 currents produced by a 200-ms depolarization to 130 mV from a holding potential of ÿ40 mV in the four myotube genotypes. To correlate the time course of the Ca 21 transient and the Ca 21 current, we compared the cumulative sum of the Ca 21 entry charge during the depolarization (i.e., the running integral of the Ca 21 current) with the fluorescence FIGURE 6 Sigmoidal and bell-shaped voltage dependence of Ca 21 transients in myotubes expressing the heterologous DHPR b2a-subunit. Ca 21 transients in DF/F units were measured in myotubes with the indicated phenotype (b1 KO, RyR3 KO, RyR1 KO and double RyR1/RyR3 KO) expressing b1a (top row) or b2a (bottom row). The depolarization duration was 50 ms (closed symbols) or 200 ms (open symbols) from a holding potential of ÿ40 mV. The same myotube was subjected to the 50-ms and 200-ms depolarization protocols. Ca 21 transients were measured at the end of each depolarization from the time course of the integrated confocal line scan image fluorescence. The lines correspond to a Boltzmann fit of the population mean DF/F indicated in Table 2 . All fluorescence vs. voltage curves were fit with Eq. 1 except those obtained with the 200 ms depolarization in myotubes overexpressing b2a, which were fit with Eq. 2. Parameters of the fitted lines (DF/Fmax in DF/F units, V1/2 in mV, and k in mV) for b1 KO overexpressing b1a are: 2.8, ÿ6.1, 7.8 for 50 ms and 3.2, ÿ10.2, 5.7 for 200 ms. Parameters for b1 KO overexpressing b2a are: 0.8, ÿ2.5, 5.8 for 50 ms and 1. 8, 9, 9.7 for 200 ms. Parameters for RyR3 KO overexpressing b1a are: 2.2, ÿ7.2, 8.2 for 50 ms and 3.2, ÿ9.9, 7.3 for 200 ms. Parameters for RyR3 KO overexpressing b2a are: 0.6, 8.5, 11.3 for 50 ms and 1.5, 3.6, 10 for 200 ms. Parameters for RyR1 KO overexpressing b2a are: 0.4, 9.8, 8.9 for 200 ms. Parameters for RyR1/RyR3 KO overexpressing b2a are: 0.2, 7.9, 10 for 200 ms. signal. We have previously argued that this is a fair comparison because Ca 21 fluorescence was measured in an internal solution containing a low EGTA concentration (0.1 mM), and, thus, the cell fluorescence tracked Ca 21 accumulation rather than the rate of SR Ca 21 release (Sheridan et al., 2003a,b) . Accordingly, the confocal fluorescence every 2.05 ms (gray dots in DF/F units), and the running integral of the Ca 21 current (smooth curve in black in units of pA 3 ms) were superimposed. For the RyR1-expressing myotubes (b1 KO and RyR3 KO) with b1a-overexpression, the fluorescence signal increased earlier and faster than the Ca 21 charge. Furthermore, the fluorescence signal saturated before termination of the 200-ms pulse, whereas the Ca 21 charge continued to increase for as long as the pulse was at 130 mV. In contrast, Ca 21 transients obtained by b2a-overexpression were considerably slower than those obtained by b1a-overexpression. Furthermore, there was a much closer agreement in the kinetics of the two signals in myotubes overexpressing b2a, which was particularly compelling in the b2a-expressing RyR1 KO myotube. In RyR1/RyR3 KO myotubes, the fluorescence signal was too noisy to permit a comparison, and, for that reason, it was not expanded. In summary, b2a overexpression eliminated the fast EC coupling typical of skeletal myotubes. Furthermore, the slow EC coupling observed in myotubes expressing b2a appears to have its kinetic basis on the slow time course of the skeletal DHPR Ca 21 current.
In the RyR1-expressing b1 KO and RyR3 KO myotubes, it could be argued that b2a induced a mixed form of EC coupling with voltage and Ca 21 serving as triggers. This is based on the fact that a pool of native DHPRs is expected to be present in these cells even after b2a-overexpression. In addition, in b1 KO and RyR3 KO myotubes overexpressing b2a, the 50-ms depolarization produced DF/F versus voltage curves with a quasi-sigmoidal shape, whereas the 200-ms depolarization induced relationships that were clearly bell-shaped ( Fig. 6) . Thus, the brief depolarization may not have been sufficient to fully activate the slow Ca 21 current but may have been sufficient to activate DHPR voltage sensors and trigger voltage-dependent EC coupling. To demonstrate if mixed voltage and Ca 21 dependent coupling had occurred, Ca 21 transients were measured in b2a-expressing b1 KO, RyR3 KO, and RyR1 KO myotubes before and after inhibition of the Ca 21 current with 2.5 mM nifedipine. Fig.  8 shows Ca 21 currents in the same myotube in response to a depolarization to 130 mV from a holding potential of ÿ40 mV. In these experiments, we used b1a-overexpressing b1 KO myotubes as a control since this isoform fully restores skeletal-type EC coupling (Beurg et al., 1997; Sheridan et al., 2003a) . In all cases, fast-perfusion with external solution containing nifedipine abolished the Ca 21 current to a level below detection (gray traces), which was ;20 pA/cell. Ca 21 transients monitored concurrently are shown before and after Ca 21 current inhibition. In the b1 KO myotubes overexpressing b1a, approximately half of the Ca 21 transient was resistant to nifedipine, consistent with previous studies in cultured skeletal myotubes (Nakai et al., 1998a; Wilkens et al., 2001) . The partial inhibitory effect of nifedipine on skeletal-type EC coupling has been previously documented and is presumably due to partial inhibition of DHPR charge movements (Rios and Pizarro, 1991) . Similarly, nifedipine produced a partial block of Ca 21 transients in RyR3 KO myotubes, consistent with the idea of mixed voltage and Ca 21 dependent coupling in this genotype. In contrast, nifedipine treatment entirely eliminated Ca 21 transients induced by b2a overexpression in b1 KO and RyR1 KO myotubes. Hence, in these cells, the Ca 21 current was overwhelmingly responsible for triggering EC coupling. In a few b2a-expressing b1 KO cells, we observed a small nifedipine-insensitive fluorescence signal, which could be attributed to a minor component of skeletal-type EC coupling promoted by b2a. However, this was not consistently observed in all batches of transfected cells, pre- sumably due to the small magnitude of the signal and the variability in the levels of the expressed protein. In summary, the pharmacological approach indicated that a mixed form of EC coupling was observed in RyR3 KO myotubes. However, the Ca 21 current appeared to be more important than voltage as EC coupling trigger in b1 KO and RyR1 KO myotubes overexpressing b2a.
The pharmacological approach using nifedipine indicated that b2a overexpression promoted Ca 21 -dependent EC coupling. However, the loss of voltage-dependent EC coupling could not be directly determined since nifedipine partially inhibited voltage sensors. To determine the extent to which voltage-dependent EC coupling was reduced by b2a overexpression, we coexpressed b2a and a Ca 21impermeant a1S pore mutant (E1014K) in a double dysgenic/b1 KO myotube lacking WT a1Sand b1asubunits. Previous studies in dysgenic (a1S-null) myotubes had shown that substitution of a critical glutamate residue at position 1014 by lysine in the pore loop of repeat III of a1S completely abolished inward Ca 21 currents, whereas skeletal-type EC coupling was restored quantitatively Ahern et al., 2001b) . Thus, by coexpressing b2a and the nonconducting a1S-subunit in a null background for both subunits, we assessed voltage-dependent EC coupling promoted directly by b2a in the absence of Ca 21 current trigger. Double mutant mice lacking a1S and b1a were obtained by interbreeding dysgenic and b1 KO mice heterozygous for the mdg and b1 KO alleles as described in Materials and Methods. Similar to dysgenic and b1 KO myotubes, double dysgenic/b1 KO myotubes were previously shown to be entirely devoid of Ca 21 currents and EC coupling. Furthermore, only by coexpressing both missing subunits in double dysgenic/b1 KO myotubes (a1S 1 b1a), was the normal skeletal myotube phenotype restored (Ahern et al., 1999) . To form the a1S/b1a and a1S/b2a subunit pairs, the b variant cDNAs were transfected in b1 KO myotubes which are otherwise WT for a1S and the other DHPR genes (Gregg et al., 1996) . To form the a1S (E1014K)/b1a pair, the mutant a1S (E1014K) cDNA was transfected in dysgenic myotubes which are otherwise WT for b1 and other DHPR genes (Chaudhari, 1992; Ahern et al., 1999; Arikkath et al., 2003) . Fig. 9 shows Ca 21 transients and Ca 21 currents at 130 mV from a holding potential of ÿ40 mV in response to a 200-ms depolarization in three myotube genotypes under the same conditions. Panel A shows a b1 KO myotube expressing b1a and separately a dysgenic myotube expressing a1S (E1014K). Panel C shows a b1 KO myotube expressing b2a and separately a double dysgenic/b1 KO myotube coexpressing a1S (E1014K) 1 b2a. Average fluorescence versus voltage and current versus voltage curves are shown in panels B and D, respectively. At 130 mV, the maximal Ca 21 current densities were ÿ5.4 6 0.3 pA/pF (10 cells) and ÿ4.6 6 0.7 (10 cells) for myotubes expressing the WT a1S/b1a and WT a1S/b2a pairs, respectively, in panels B and D. In contrast, the pore mutant inward currents at the same potential were below the level of detection (;0.05 pA/pF), in agreement with previous results Ahern et al., 2001b) . Outward currents at potentials more positive than 130 mV correspond to a mixture of background currents present in the cultured myotube and outward monovalent current through the pore mutant Ca 21 channel (Yang et al., 1993) .
As indicated by the average DF/F curves in Fig. 9 B, Ca 21 transients of a comparable maximal magnitude and sigmoidal voltage dependence were obtained in b1 KO myotubes expressing b1a and dysgenic (labeled mdg) myotubes expressing a1S (E1014K). Thus, expressed DHPRs carrying either a WT or a pore-mutant a1S-subunit were capable of restoring voltage-dependent EC coupling. This result is in accordance with the well-known lack of involvement of the L-type Ca 21 current as EC coupling trigger in skeletal FIGURE 8 Nifedipine-sensitive Ca 21 transients expressed by the heterologous DHPR b2a-subunit in b1 KO, RyR3 KO, and RyR1 KO myotubes. From left to right, the panels show Ca 21 transients, Ca 21 currents, and fluorescence versus voltage curves for b1a in b1 KO, b2a in b1 KO, b2a in RyR3 KO, and b2a in RyR1 KO myotubes. Myotubes were depolarized for 200 ms from a holding potential of ÿ40 mV to 130 mV in external solution with 10 mM Ca 21 . Ca 21 transients and Ca 21 currents were measured in the same myotube before and after block of the Ca 21 current with 2.5 mM nifedipine. Time course of the Ca 21 transient and Ca 21 current after nifedipine inhibition is shown in gray. The time course of the cell fluorescence was obtained by integration of the line scan image as described in Materials and Methods. Graphs show the fit of voltage dependence of the maximal DF/F during the depolarization using Eq. 1 for b1a overexpression or Eq. 2. for b2a overexpression. Gray symbols show fluorescence versus voltage curve after myotube exposure to nifedipine. muscle and, more specifically, with the behavior of a1S (E1014K) in previous studies in dysgenic myotubes Ahern et al., 2001b) . In contrast, Ca 21 transients in double dysgenic/b1 KO myotubes expressing a1S (E1014K) and b2a in Fig. 9 D were substantially smaller than those in b2a-expressing b1 KO myotubes. Thus, elimination of the pore function in the a1S-subunit curtailed the magnitude of the Ca 21 transient when b2a formed part of the DHPR complex. Moreover, the fluorescence versus voltage curve was bell-shaped in the case of the WT a1S/b2a pair but sigmoidal for the a1S (E1014K)/b2a pair, consistent with the idea that the pore mutant DHPR contributed only to voltage-dependent EC coupling. The bell-shaped fluorescence versus voltage curve for the WT a1S/b2a pair was in agreement with data in Fig.  6 . From the magnitude of Ca 21 transients in b2a-expressing b1 KO myotubes and a1S (E1014K) 1 b2a-expressing double dysgenic/b1 KO myotubes in Fig. 9 D, we estimated that the voltage-dependent component of EC coupling was ;20% of the total Ca 21 transient at 130 mV. From these observations we concluded that the DHPR b2a-subunit eliminated a sizable amount of voltage-dependent EC coupling despite the presence of a WT a1S pore subunit. Hence, in myotubes overexpressing b2a and lacking b1a, Ca 21 entry dominates over voltage as EC coupling trigger.
DISCUSSION
This work shows that replacement of the skeletal DHPR b1a-subunit by the cardiac/brain variant b2a, in the context of a WT a1S pore subunit, modifies the EC coupling signal from one controlled by voltage to one controlled by the Ca 21 current. The changes in EC coupling were most pronounced in b1 KO myotubes and, by comparison to b1a, b2a produced an overall decrease in the amplitude of Ca 21 transients with evident changes in the shape of the Ca 21 fluorescence versus voltage relationship, slowing of the kinetics of the Ca 21 transient, and a dependence of Ca 21 transients on the Ca 21 current. These observations, the pharmacological interventions using nifedipine, and the results in double dysgenic/b1 KO myotubes are all consistent with a loss in voltage-dependent EC coupling and emergence of Ca 21 -dependent EC coupling triggered by the slow L-type DHPR Ca 21 current. Partial changes in the same direction were also observed when b2a was overexpressed in the presence of a native skeletal DHPR, such as in RyR3 KO myotubes. In this case, b2a appeared to have acted as a negative dominant which is presumably due to the inability of the functional hybrid DHPR composed of skeletal subunits and b2a to fully engage in skeletal-type EC coupling. Overall, the changes promoted by the b2asubunit are mechanistically important since, until this work, only cardiac/brain DHPR a1 pore subunits (Garcia et al., 1994; Nakai et al., 1998a) , were known to introduce Ca 21dependent EC coupling in skeletal myotubes.
By comparing DF/F max for the a1S (E1014K)/b1a and a1S (E1014K)/b2a subunit pairs we can roughly estimate the loss in skeletal-type EC coupling when b1a is replaced by b2a in the DHPR complex. DF/F max was 4 6 0.6 (5 cells) and 0.3 6 0.1 (8 cells), respectively. Hence, voltage FIGURE 9 Ca 21 transients and Ca 21 currents expressed by the heterologous DHPR b2a-subunit in a1S/b1-null myotubes. Ca 21 transients and Ca 21 currents in the same myotube at 130 mV from a holding potential of ÿ40 mV in response to a 200-ms depolarization. Panel A shows a b1 KO myotube transfected with b1a (black traces) and a dysgenic myotube (labeled mdg) transfected with a1S (E1014K) (gray traces). Panel B shows average fluorescence versus voltage and current versus voltage curves for b1 KO myotubes expressing b1a (black traces) and dysgenic myotubes expressing a1S (E1014K) (gray traces). Fluorescence and whole cell current data are shown for 10 and 5 cells in black and gray symbols, respectively. Panel C shows a b1 KO myotube transfected with b2a (black traces) and a double dysgenic /b1 KO myotube cotransfected with b2a and a1S (E1014K) (gray traces). Panel D shows average fluorescence versus voltage and current versus voltage curves for b1 KO myotubes expressing b2a (black traces) and for double dysgenic/b1 KO myotubes coexpressing b2a 1 a1S (E1014K) (gray traces). Fluorescence and whole cell current data are shown for 10 and 8 cells in black and gray symbols, respectively. Parameters of the Boltzmann fit of fluorescence were DF/F max in DF/F units, V1/2 in mV, and k in mV) were 4 6 0.6, 1 6 6, 8 6 1.1 (a1S (E1014K), 5 cells) and 0.3 6 0.1, 24 6 5, 9.3 6 1.3 (b2a 1 a1S (E1014K), 8 cells). Parameters for b1a and b2a expressing cells in b1 KO myotubes are shown in Table 2. was ;10-fold less effective as a trigger signal when the skeletal DHPR included the cardiac/brain b2a isoform as a b-subunit. This occurred despite the fact that Ca 21 current densities and previously estimated single-channel open probabilities were similar when b2a replaced b1a in the context of a WT a1S pore subunit (Beurg et al., 1999b) . Thus, DHPR densities were likely to be similar when either b1a or b2a formed part of the DHPR complex. Based on the small magnitude of the voltage-dependent component, we would have predicted stronger differences in Ca 21 transient amplitudes in b2a-expressing myotubes for 50-ms and 200-ms depolarizations since the brief depolarization injects between 5-fold and 130-fold less Ca 21 charge into the cell depending on channel kinetics (Sheridan et al., 2003a) . Instead, Fig. 6 shows only a twofold difference in Ca 21 transient fluorescence at 130 mV for 50 ms and 200 ms in b2a-transfected b1 KO myotubes. It is entirely possible that a voltage-activated Ca 21 release component, even if small, may lead to an explosive activation of nearneighbor RyRs by a Ca 21 -dependent mechanism. Hence the comparatively large activation of Ca 21 release seen at 50 ms may not reflect the magnitude of the voltage-dependent component. Rather, it may reflect the effect of the voltagedependent component on a much larger population of RyR channels, most of them activated by Ca 21 released from a few voltage-activated RyRs. Such a mechanism has been suggested for Ca 21 spark formation in frog skeletal and cardiac muscle. However, its applicability to mammalian skeletal muscle still is under investigation (Stern et al., 1997) . It is also possible that the absence of normal interaction between the DHPR and RyR1 when b2a is present renders RyR1 more Ca 21 -sensitive such that smaller Ca 21 currents may recruit a larger density of Ca 21 -activated RyR channels. Both possibilities suggest synergistic interactions between voltage and Ca 21 as trigger signals which remain to be investigated in more detail.
The observed loss of voltage-dependent and gain of Ca 21dependent EC coupling, in the context of a WT a1S-subunit, implies a change in the mechanism of interaction of the DHPR and RyR1. Structural studies have shown that, at transverse tubular-SR junctions, four DHPRs arranged as a square tetrad hover over the cytoplasmic surface of a single RyR1 tetramer (reviewed by Franzini-Armstrong and Protasi, 1997). This anatomical arrangement, and the minimal distance separating the SR and surface-connected membranes at these locations, has provided compelling evidence in favor of a protein-to-protein ''mechanical-type'' coupling between the skeletal DHPR and RyR1. The EC coupling signal transferred from the voltage sensor to RyR1 may thus involve some form of mechanical torque exerted on the foot structure of RyR1 initiated by voltage sensor movement. The essence of this concept was originally proposed by Chandler et al. (1976) , although the nature of the protein complexes involved in voltage sensing and SR Ca 21 release were not known at the time. In this context, the EC coupling changes promoted by b2a-subunit are most easily visualized as a partial undocking of the DHPR and RyR1 complexes. Ca 21 -dependent EC coupling might thus result from a partially-docked DHPR-RyR1 complex in which the voltage signal is unable to open a significant number of RyR1 channels. Those RyR1 channels not activated by voltage might be available for activation by the Ca 21 current provided that the DHPR and the RyR1 remain co-localized. It could be further argued that in normal circumstances, the Ca 21 current has no impact on EC coupling because during a brief depolarization, and before the full activation of the Ca 21 current, the complete pool of RyR channels in a given release unit is rapidly and synchronically activated. Some of the RyR1 channels would be directly activated by voltage via ''mechanical'' coupling to the DHPR and others would be activated by the Ca 21 released from the nearest voltage-activated RyR1 channel. Rapid and synchronic activation of voltage-dependent and Ca 21 -dependent RyR channels has been proposed to occur during Ca 21 spark formation in adult skeletal muscle (Stern et al., 1997) .
Expression of the native DHPR Ca 21 current appears to be under the specific control of RyR1 by a so-called retrograde signal from RyR1 to the DHPR. This retrograde signal is probably structural in origin since a WT Ca 21 current density was observed in RyR1 KO myotubes expressing RyR1 mutants deficient in EC coupling (Avila et al., 2001) . Recent studies showed that the requirement of the DHPR for RyR1 could be bypassed by molecular determinants present on the amino terminus of b2a . Ca 21 currents were present at a WT density in RyR1 KO myotubes overexpressing b2a or b2a-b1a chimeras carrying domains D1, D2, and D3 of b2a . Two vicinal cysteines in domain D1, a putative palmitoylation motif, were critical for the b2a-mediated Ca 21 current recovery. Furthermore, tethering b2a to the myotube surface by a transmembrane motif in the absence of the two vicinal cysteines in domain D1 also increased Ca 21 current expression in the absence of RyR1. Thus, the conformational state of the b-subunit, or preferential locations of the b-subunit close to the plasma membrane, are crucial for DHPR Ca 21 current expression. In the native DHPR, such a specific conformation of the b-subunit may be reached through a direct interaction with RyR1 . However, we realize that Ca 21 current regulation in the skeletal DHPR is quite complex and that it involves molecular determinants present in a1S (Grabner et al., 1999) , RyR1 (Nakai et al., 1998b) , as well as in the b-subunit . Even though the mechanism for Ca 21 current enhancement by b2a has been outlined, it could still be argued that b2a either recruited other pore subunits in the culture myotube and/or redirected the DHPR to surface locations away from EC coupling sites. Functional evidence gathered previously Sheridan et al., 2003a) and in this work, indicates that both possibilities are unlikely. As already mentioned, transfection of b1a in a dysgenic a1S-null myotube does not result in expression of Ca 21 currents (not shown). Therefore, non-a1S pore subunits that could account for Ca 21 current recovery by b2a are not present in the cultured myotube. Furthermore, we could not detect significant differences in the skeletal-type EC coupling abilities of b2a-b1a chimeras with and without the double cysteine motif, provided that the carboxyl terminus of b1a was present . This result argues that the double cysteine motif does not have an intrinsic ability to relocate the DHPR to new sites in the myotube surface away from the junctional SR region. These reasons, and the fact that Ca 21 -dependent release was observed, altogether, make it likely that hybrid DHPRs that include a1S and b2a are present at SR junctions but are not strongly docked to RyR1. Strong co-localization is a condition sine qua non for observing Ca 21 -dependent release since other high-density Ca 21 currents in the myotube such as those originating from T-type Ca 21 channels do not release SR Ca 21 (Ahern et al., 2001d) .
This work implicates RyR3 in SR Ca 21 release in cultured skeletal myotubes. RyR3 is widely expressed in fetal limb muscles, abdominal muscles, and in the diaphragm (Bertocchini et al., 1997) . During the neonatal phase, RyR3 expression is drastically reduced, whereas in the adult musculature, this isoform is almost exclusively confined to the diaphragm and soleus muscles (Bertocchini et al., 1997; Flucher et al., 1999) . Hence, the presence of RyR3 in cultured myotubes derived from limb fetal tissue is not surprising, and our observation is in agreement with a previous report (Takeshima et al., 1995) . In b1a-overexpressing and nontransfected RyR3 KO myotubes, the 200ms depolarization evoked more release, i.e., a higher DF/ F max , than the shorter 50-ms depolarization. This behavior was not present in either WT or b1a-expressing b1 KO myotubes (Table 1) . RyR3 is known to form functional Ca 21 release units, as demonstrated by its ability to generate spontaneous Ca 21 spark-like Ca 21 release events in several expression systems (Conklin et al., 2000; Ward et al., 2000; Rossi et al., 2002) . Furthermore, RyR3 is present in transverse tubular-SR junctions (Flucher et al., 1999) and contributes substantially to the kinetics and overall dimensions of Ca 21 sparks in WT muscle cells (Conklin et al., 2000) . In cultured myotubes, Ca 21 release sites are present in peripheral couplings established between junctional SR and surface membranes . Confocal studies in cultured myotubes have shown that the rate of SR Ca 21 release propagation from the edge to the center of the cell is considerably slower in RyR3 KO than in RyR3-expressing controls. Thus, a significant functional role of RyR3 channels is to synchronize the macroscopic Ca 21 release transient in different regions of the myotube (Yang et al., 2001) . Our findings are consistent with this observation, since a brief depolarization is expected to be less effective than a longer depolarization in speeding inward Ca 21 release propagation. In our data, this would be manifested as a decrease in the space-averaged fluorescence. It is interesting to note that a decrease in space-averaged Ca 21 fluorescence is also evident in the line scan images in Fig. 1 B of Yang et al. (2001) comparing RyR3-deficient and RyR3expressing myotubes, although calculations were not reported. Mammalian RyR3 channels have a mean open time much longer than RyR1 channels (Chen et al., 1997) and a lower sensitivity to inactivation by Ca 21 (Sonnleitner et al., 1998) and Mg 21 (Murayama and Ogawa, 1997) . We would speculate that during a Ca 21 transient, RyR3 channels remain open for longer periods than RyR1 channels. The overall result would be a local positive reinforcement of Ca 21 release, and this could be the basis for the enhancement in Ca 21 fluorescence observed with the 200-ms depolarization. Our observations in RyR1 KO myotubes further indicate that RyR3 is capable of engaging in Ca 21 release triggered directly by the Ca 21 current. Hence, RyR3 may not only amplify Ca 21 release initiated by RyR1, but, in addition, RyR3 may be a recipient of a bona fide Ca 21 current trigger signal.
The changes in the EC coupling trigger signal, from voltage to Ca 21 entry, promoted by b2a in b1 KO myotubes, are entirely analogous to the changes in EC coupling observed previously when a1S was replaced by the cardiac a1C-subunit in the cellular context of a primary dysgenic a1S-null skeletal myotube (Tanabe et al., 1990; Garcia et al., 1994) . The functional analogy extends also to Ca 21 current regulation since a1C, like b2a, expresses high-density Ca 21 currents in RyR1 KO myotubes (Carbonneau et al., 2003; unpublished) . Hence, Ca 21 current expression in a DHPR that includes a1C is not functionally inhibited by the absence of RyR1. The similar outcome of these two sets of experiments, namely a1S replacement by a1C versus b1a relacement by b2a, suggests to us that in the native DHPR, critical interactions with RyR1 responsible for orthograde and retrograde coupling are controlled by conformational states in both a1S and the b-subunit. Hence, we would suggest that the a1S/b pair, and not each subunit alone, controls the EC coupling signal in skeletal myotubes. Whether the role of the b-subunit is to facilitate DHPR-RyR1 docking, i.e., a structural role, or is directly involved in the transmission of the molecular signal to RyR1, is currently under investigation. Both possibilities are suggested by mutagenesis experiments in which deletion of EC domains present in the a1S II-III loop did not entirely abolish voltage-dependent Ca 21 transients (Ahern et al., 2001b) and by the fact that b1a binds directly to RyR1 . This work was supported by the National Institutes of Health Grants AR46448 and HL47053 to R.C., predoctoral fellowships from the Wisconsin Heart Association to D.C.S., and predoctoral fellowships from the National Institutes of Health Training Grant T32 HL07936 to C.A.A. and L.C. RyR1 KO mice were a gift of Dr. P.D. Allen, and RyR3 KO were a gift of Dr. V. Sorrentino.
